eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Laryngology

Laryngeal Manifestations of Parkinson Disease

Author: Thomas L Carroll, MD, Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, Tufts Medical Center, Tufts University School of Medicine
Coauthor(s): Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine; Lorraine Ramig, PhD, Professor, Department of Speech Language Hearing Sciences, University of Colorado at Boulder; Senior Scientist, National Center for Voice and Speech (NCVS); Adjunct Professor, Department of Biobehavior, Columbia University Teacher's College
Contributor Information and Disclosures

Updated: Oct 7, 2009

Introduction

Background

First described by James Parkinson in 1817, parkinsonism is a neurological syndrome that manifests as a combination of bradykinesia, rigidity, resting tremor, and loss of postural reflexes. For the diagnosis of parkinsonism to be made, at least 2 of these features should be present, with one of the two being either rigidity or tremor.

The cause of parkinsonism can be divided into the following 3 areas:

  • Idiopathic Parkinson disease (IPD) is the most common form and serves as the focus of this article.
  • Secondary Parkinson disease includes the features of IPD but has an identifiable cause such as a medication's side effect, a head trauma, or a tumor.
  • Parkinsonism-plus syndromes (PPS) include diseases in which the symptoms of IPD have a known genetic defect or distinctive pathologic changes such as multiple system atrophy, corticobasal ganglionic degeneration, or progressive supranuclear palsy.

IPD often begins insidiously, with tremor as the first presenting symptom. The tremor is first seen in the distal parts of the extremities and in the lips and is commonly described as "pill rolling" in the hands. Unlike other tremors, the extremity tremors cease upon active limb movement. Bradykinesia (masked facies, drooling, decreased blinking, shuffling gate, trouble with transfers from chairs and automobiles, difficulty with dexterous hand movements), rigidity (resistance to passive movement), and loss of postural reflexes (leading to a tendency to fall, stooped posture, and festination) all contribute to the morbidity associated with IPD. Interestingly, patients with IPD and their families often report reduced ability to communicate as the most significant associated problem.

This feature requires the newest version of Flash. You can download it here.

Elliptical closure pattern pre–Lee Silverman Voice Treatment (LSVT) and resolved post-LSVT.

Elliptical closure pattern pre–Lee S...

Elliptical closure pattern pre–Lee Silverman Voice Treatment (LSVT) and resolved post-LSVT.


The laryngeal manifestations of IPD often lead to decreased participation in the activities of daily living because of an inability to communicate effectively. During the course of the disease, 45-89% of patients report speech problems, and more than 30% find speech problems to be the most debilitating part of the disease. Despite the significant number of patients with vocal symptoms, only an estimated 3-4% of patients with IPD undergo speech therapy. Patients with IPD usually present with symptoms of hypokinetic dysarthria, including a monotone, soft voice with a breathy, hoarse voice quality and imprecise articulation. Vocal tremor, repetitive speech, and decreased facial expressions also contribute to communication difficulties.

Most patients with IPD do not recognize the problems that need to be overcome for them to effectively communicate; these problems include decreased neural drive to the larynx muscles, decreased sensory feedback that allows vocal shortcoming correction, and difficulty internally generating an acceptable speech volume. Treatments for IPD, including neuropharmacological and neurosurgical methods, offer effective therapy for limb symptoms, but their effects on vocal symptoms are not consistently or significantly effective and are not as well studied. Speech therapy is effective in treating the laryngeal manifestations of IPD.

Pathophysiology

Parkinson disease is primarily a result of the loss of pigmented dopaminergic neurons in the substantia nigra. Lewy bodies, eosinophilic inclusions in the cytoplasm of intact neurons, are often present. Lewy bodies are characteristic but not pathognomonic of IPD. A loss of dopamine allows an increased inhibitory output from the globus pallidus, causing the hypokinetic symptoms.

Frequency

United States

IPD is the most common movement disorder in patients older than 55 years. The incidence is estimated to be 4.5-21 cases per 100,000 persons per year. The prevalence is estimated to be 120 per 100,000 persons. Prevalence increases with age.

Sex

IPD is 1.5 times more common in men than in women.

Age

The average age of onset is in the seventh decade of life.

Clinical

History

A complete neurolaryngological evaluation must be completed. This includes a detailed history, evaluation of the voice, neurolaryngeal evaluation, and stroboscopy.

Patients are usually diagnosed with idiopathic Parkinson disease (IPD) before examination, although some patients are diagnosed based on their presenting vocal symptoms. The physician evaluating the voice must be vigilant about the possibility of IPD in patients who do not yet carry the diagnosis, and physicians should refer to a neurologist appropriately. As with any other medical history, discovering the nature of the symptoms (including when the symptoms began, if anything improves or worsens the symptoms, if the symptoms fluctuate, or if the symptoms are constant) is important. Particularly in patients with IPD, the physician must elicit the frustrations that the patient and patient's family are experiencing. Often, rather than recognizing their vocal shortcomings, patients feel like those around them are not listening or are becoming hard of hearing.

Evaluation of the voice 

  • As the patient is speaking, the vocal loudness, intonation, and vocal quality, including fluidity of speech and articulation, should be assessed. Sustaining vowel phonation (eg, "ah") for maximum duration, counting to 50, and reading passages such as the rainbow passage provide reasonable speech samples. Closely listening for reduced and diminishing loudness and intonation and increasing breathiness and hoarseness helps to differentiate IPD from hyperkinetic disorders such as spasmodic dysphonia.1  
  • A soft, monotone voice, vocal tremor, poor articulation, variable speech rate, trouble with the initiation of speech, stutteringlike qualities, and masked facies or flat affect are all characteristics of IPD. Perhaps the most telling vocal symptom is the marked contrast in vocal loudness between habitual loudness (soft and diminishing) and the patient's response to a request to increase loudness. A request to "say that again, twice as loud" often results in increased loudness, improved voice quality, and a dramatic improvement in speech intelligibility.
  • Neurolaryngeal examination
    • Because distortion can occur when the tongue is held forward during rigid stroboscopy, the neurolaryngeal examination is best performed by viewing the larynx with a flexible laryngoscope. The larynx is evaluated for vocal fold mobility, paresis or paralysis, coordination of movement, agility, fatigability, flexibility, and use of accessory muscles during phonation while the patient says various phrases and syllables. Hyperfunctional and hypofunctional disorders can often be differentiated by isolating the abductor and adductor muscle groups. The larynx is also visualized at rest. Perez et al found that vocal tremor is present in 55% of patients with IPD.2 They found that only 35% of patients with IPD exhibit a resting tremor, while the remainder exhibited kinetic tremor (a goal-directed movement tremor). The tremor is primarily a vertical laryngeal movement. This is somewhat unexpected because limb tremor in IPD is usually a resting tremor and not a kinetic tremor.
    • Parkinson-plus syndromes (PPS) are found to carry a higher incidence of tremor (64%). Most tremors are located in the arytenoids. Perez et al found no vertical laryngeal tremor in patients with PPS.2
  • Stroboscopy: Rigid stroboscopy plays a key role in the assessment of the vibratory characteristics of the vocal folds, including the presence of masses, lesions, or scar and glottic configuration abnormalities, including an elliptical closure pattern, phase asymmetry, and abnormal phase closure. Stroboscopy and neurolaryngeal examination are complementary in the evaluation of the patient with IPD. Common stroboscopy findings in IPD include true vocal fold atrophy or other evidence of glottal incompetence, including a chasing wave or a shorter closed phase. Pooling of secretions, decreased sensation, and aspiration are also characterizations of the IPD larynx. A paralyzed vocal fold suggests PPS as the etiology for the parkinsonism if other aspects of the diagnosis are present.

Causes

Most cases of IPD are believed to be caused by a combination of genetic and environmental factors.

More on Laryngeal Manifestations of Parkinson Disease

Overview: Laryngeal Manifestations of Parkinson Disease
Differential Diagnoses & Workup: Laryngeal Manifestations of Parkinson Disease
Treatment & Medication: Laryngeal Manifestations of Parkinson Disease
Follow-up: Laryngeal Manifestations of Parkinson Disease
Multimedia: Laryngeal Manifestations of Parkinson Disease
References

References

  1. Brin MF, Velickovic M, Ramig LO. Dysphonia due to Parkinson's disease: pharmacological, surgical, and behavioral management perspectives. In: Vocal rehabilitation in medical speech-language pathology. Austin: Pro-Ed; 2004:209-69.

  2. Perez KS, Ramig LO, Smith ME, Dromey C. The Parkinson larynx: tremor and videostroboscopic findings. J Voice. Dec 1996;10(4):354-61. [Medline].

  3. Berke GS, Gerratt B, Kreiman J, Jackson K. Treatment of Parkinson hypophonia with percutaneous collagen augmentation. Laryngoscope. Aug 1999;109(8):1295-9. [Medline].

  4. Belafsky PC, Postma GN. Vocal fold augmentation with calcium hydroxylapatite. Otolaryngol Head Neck Surg. Oct 2004;131(4):351-4. [Medline].

  5. Brin MF, Fahn S, Blitzer A. Movement disorders of the larynx. In: Neurologic disorders of the larynx. New York: Thieme Medical Publishing; 1992:248-78.

  6. de Swart BJ, Willemse SC, Maassen BA, Horstink MW. Improvement of voicing in patients with Parkinson's disease by speech therapy. Neurology. Feb 11 2003;60(3):498-500. [Medline].

  7. Fox CM, Morrison CE, Ramig LO. Current perspectives on the Lee Silverman Voice Treatment (LSVT) for individuals with idiopathic parkinson disease. Am J Speech Lang Pathol. 2002;11:111-23.

  8. Kim SH, Kearney JJ, Atkins JP. Percutaneous laryngeal collagen augmentation for treatment of parkinsonian hypophonia. Otolaryngol Head Neck Surg. Jun 2002;126(6):653-6. [Medline].

  9. Liotti M, Ramig LO, Vogel D, et al. Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET. Neurology. Feb 11 2003;60(3):432-40. [Medline].

  10. Merati AL, Heman-Ackah YD, Abaza M, Altman KW, Sulica L, Belamowicz S. Common movement disorders affecting the larynx: a report from the neurolaryngology committee of the AAO-HNS. Otolaryngol Head Neck Surg. Nov 2005;133(5):654-65. [Medline].

  11. Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease. J Neurol. Feb 2003;250(2):179-87. [Medline].

  12. Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurol. Sep 2004;3(9):547-56. [Medline].

  13. Pützer M, Barry WJ, Moringlane JR. Effect of bilateral stimulation of the subthalamic nucleus on different speech subsystems in patients with Parkinson's disease. Clin Linguist Phon. Dec 2008;22(12):957-73. [Medline].

  14. Ramig LO, Fox C, Sapir S. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Semin Speech Lang. May 2004;25(2):169-80. [Medline].

  15. Ramig LO, Fox C, Sapir S. Speech treatment for Parkinson's disease. Expert Rev Neurother. Feb 2008;8(2):297-309. [Medline].

  16. Sanabria J, Ruiz PG, Gutierrez R, et al. The effect of levodopa on vocal function in Parkinson's disease. Clin Neuropharmacol. Mar-Apr 2001;24(2):99-102. [Medline].

  17. Sapir S, Ramig LO, Hoyt P, Countryman S, O'Brien C, Hoehn M. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment. Folia Phoniatr Logop. Nov-Dec 2002;54(6):296-303. [Medline].

  18. Smith ME, Ramig LO, Dromey C, Perez KS, Samandari R. Intensive voice treatment in Parkinson disease: laryngostroboscopic findings. J Voice. Dec 1995;9(4):453-9. [Medline].

Further Reading

Keywords

laryngeal manifestations, Parkinson disease, Parkinsons disease, Parkinson’s disease, bradykinesia, resting tremor, Parkinsonism, idiopathic Parkinson disease, IPD, vocal tremor, tremor, rigidity, postural reflexes, hypokinesia, hypokinetic, stroboscopy

Contributor Information and Disclosures

Author

Thomas L Carroll, MD, Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, Tufts Medical Center, Tufts University School of Medicine
Thomas L Carroll, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

Lorraine Ramig, PhD, Professor, Department of Speech Language Hearing Sciences, University of Colorado at Boulder; Senior Scientist, National Center for Voice and Speech (NCVS); Adjunct Professor, Department of Biobehavior, Columbia University Teacher's College
Disclosure: Nothing to disclose.

Medical Editor

B Viswanatha, MBBS, MS, DLO, Professor of ENT, Sri Venkateshwara ENT Institute, Victoria Hospital, Bangalore Medical College and Research Institute, India
B Viswanatha, MBBS, MS, DLO is a member of the following medical societies: Association of Otolaryngologists of India, Indian Medical Association, and Indian Society of Otology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Robert M Kellman, MD, Professor and Chair, Department of Otolaryngology and Communication Sciences, State University of New York, Upstate Medical University
Robert M Kellman, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Neurotology Society, American Rhinologic Society, American Society for Head and Neck Surgery, Medical Society of the State of New York, and Triological Society
Disclosure: GE Healthcare Honoraria Review panel membership

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.